Literature DB >> 15371948

Congenital hyperinsulinism: intraoperative biopsy interpretation can direct the extent of pancreatectomy.

Mariko Suchi1, Paul S Thornton, N Scott Adzick, Courtney MacMullen, Arupa Ganguly, Charles A Stanley, Eduardo D Ruchelli.   

Abstract

Most cases of congenital hyperinsulinism (HI) manifest as either a diffuse or focal form. Diffuse HI is characterized by the presence of enlarged islet cell nuclei, defined as those occupying an area 3 times larger than the surrounding nuclei, throughout the pancreas, and usually requires near total pancreatectomy. Focal HI contains, within an otherwise normal pancreas with islet cell nuclei of normal size, a focus of adenomatous hyperplasia characterized by endocrine cell overgrowth occupying more than 40% of a given area. This form of HI is amenable to partial pancreatectomy. The current study assesses whether intraoperative frozen section evaluation can distinguish the 2 forms and guide the extent of pancreatectomy. By frozen section analysis, diffuse HI is diagnosed when enlarged islet cell nuclei are present in random intraoperative biopsies from the head, body, and tail of the pancreas. Focal HI is suggested when random biopsies contain no large islet cell nuclei, prompting a further search for a focal lesion. Fifty-two HI patients who underwent pancreatectomy from October 1, 1998 to September 30, 2002 were reviewed. On permanent sections, 18 were classified as diffuse HI, 30 had focal HI, and 4 could not be categorized as either. Among 18 diffuse HI patients, 17 were correctly diagnosed by frozen section; all underwent near total pancreatectomy. One case was interpreted as not belonging to typical diffuse or focal HI; however, the permanent sections showed diffuse HI. Twenty-six of 30 focal HI cases were correctly diagnosed by frozen section. The remaining 4 focal HI cases posed diagnostic difficulties on frozen sections because of one the following reasons: 1) presence of equivocally large islet cell nuclei or rare truly large islet cell nuclei in areas nonadjacent to the focal lesion, and 2) large and/or ill defined focus of adenomatous hyperplasia. Twenty-one of 30 focal HI patients eventually had 10% to 93% (mean, 41.8%) of their pancreas resected. In addition to cases typical for diffuse and focal HI, there were 4 other cases whose pancreata did not fit well with either category. These pancreata showed islet cell nuclear enlargement, as characteristically seen in diffuse HI, but only in confined areas of the pancreas. Examination of routinely processed tissue confirmed frozen section findings in all 4 cases. Intraoperative frozen section evaluation, therefore, can assume an essential role in identifying patients with focal HI to limit the extent of pancreatectomy. However, a small number of cases with unusual histology warrant caution when performing frozen section evaluation.

Entities:  

Mesh:

Year:  2004        PMID: 15371948     DOI: 10.1097/01.pas.0000138000.61897.32

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.

Authors:  Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

2.  Single incision laparoscopic 90 % pancreatectomy for the treatment of persistent hyperinsulinemic hypoglycemia of infancy.

Authors:  Jin-Shan Zhang; Long Li; Wei Cheng
Journal:  Pediatr Surg Int       Date:  2016-07-29       Impact factor: 1.827

Review 3.  Hyperinsulinism presenting in childhood and treatment by conservative pancreatectomy.

Authors:  Mary E Patterson; Catherine S Mao; Michael W Yeh; Eli Ipp; Galen Cortina; David Barank; Panukorn Vasinrapee; Anna Pawlikowska-Haddal; W N Paul Lee; Jennifer K Yee
Journal:  Endocr Pract       Date:  2012 May-Jun       Impact factor: 3.443

4.  Efficacy and safety of octreotide treatment for diazoxide-unresponsive congenital hyperinsulinism in China.

Authors:  Bingyan Cao; Wu Di; Chang Su; Jiajia Chen; Xuejun Liang; Min Liu; Wenjing Li; Xiaoqiao Li; Chunxiu Gong
Journal:  Pediatr Investig       Date:  2020-03-17

5.  Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-Channel.

Authors:  Rachel J Salisbury; Bing Han; Rachel E Jennings; Andrew A Berry; Adam Stevens; Zainab Mohamed; Sarah A Sugden; Ronald De Krijger; Sarah E Cross; Paul P V Johnson; Melanie Newbould; Karen E Cosgrove; Karen Piper Hanley; Indraneel Banerjee; Mark J Dunne; Neil A Hanley
Journal:  Diabetes       Date:  2015-04-30       Impact factor: 9.461

6.  Clinical practice guidelines for congenital hyperinsulinism.

Authors:  Tohru Yorifuji; Reiko Horikawa; Tomonobu Hasegawa; Masanori Adachi; Shun Soneda; Masanori Minagawa; Shinobu Ida; Takeo Yonekura; Yoshiaki Kinoshita; Yutaka Kanamori; Hiroaki Kitagawa; Masato Shinkai; Hideyuki Sasaki; Masaki Nio
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

7.  Unravelling the genetic causes of mosaic islet morphology in congenital hyperinsulinism.

Authors:  Jayne Al Houghton; Indraneel Banerjee; Guftar Shaikh; Shamila Jabbar; Thomas W Laver; Edmund Cheesman; Amish Chinnoy; Daphne Yau; Maria Salomon-Estebanez; Mark J Dunne; Sarah E Flanagan
Journal:  J Pathol Clin Res       Date:  2019-10-29

8.  Suspected congenital hyperinsulinism in a Shiba Inu dog.

Authors:  Simon Cook; Myles McKenna; Barbara Glanemann; Ranbir Sandhu; Chris Scudder
Journal:  J Vet Intern Med       Date:  2020-06-27       Impact factor: 3.333

Review 9.  Congenital hyperinsulinism: current status and future perspectives.

Authors:  Tohru Yorifuji
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30

10.  Intraoperative ultrasound imaging in the surgical treatment of congenital hyperinsulinism: prospective, blinded study.

Authors:  A P Bjarnesen; P Dahlin; E Globa; H Petersen; K Brusgaard; L Rasmussen; M Melikian; S Detlefsen; H T Christesen; M B Mortensen
Journal:  BJS Open       Date:  2021-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.